1 Min Read
Bio-Sourcing and Zerion Pharma have announced that their collaboration to develop an oral form of the monoclonal antibody trastuzumab for breast cancer has received 1.3m euros in funding from EUREKA Eurostars. The collaboration combines Bio-Sourcing’s BioMilk platform, designed to transport biologics through the gastrointestinal tract, with Zerion’s Dispersome technology. This technology has the capacity for […] The post Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project appeared first on Pharmafile.
Work & Theory on January 17, 2026
Uncategorized